Financial Data and Key Metrics Changes - Q4 revenues reached a record $1.048 billion, up 5.3% year-over-year and 5.2% sequentially [5] - For the full year 2025, total revenues were a record $4 billion, up 1% year-over-year [5] - Q4 overall gross margin was 65.3%, up 1.1 points sequentially but down 4.8 points year-over-year [40][41] - Q4 net income per diluted share was $1.89, up $1.11 sequentially and up $0.50 year-over-year [51] Business Line Data and Key Metrics Changes - Systems and services revenues were $790 million, up 2.7% year-over-year [6] - Clear aligner revenues for Q4 were $838 million, up 5.5% year-over-year and up 4% sequentially [7][34] - Fiscal 2025 clear aligner revenues were $3.2 billion, up 0.5% year-over-year on record clear aligner volumes of 2.6 million cases [6] Market Data and Key Metrics Changes - Q4 clear aligner volume was a record 677,000 cases, up 7.7% year-over-year [8] - In EMEA, clear aligner volumes grew double digits year-over-year, with significant growth in Iberia, the Nordics, and the UK [18] - In APAC, clear aligner volumes also grew double digits year-over-year, with record shipments from China, India, and Korea [19] Company Strategy and Development Direction - The company is focusing on expanding international adoption and increasing orthodontic utilization, particularly among teens and kids [62] - Strengthening consumer demand conversion through localized last-mile marketing is a key strategy [62] - The company aims to enhance its digital platform and maintain leadership in treatment planning and 3D printing manufacturing [12] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the macro environment while highlighting strong fundamentals and execution [61][66] - The company expects Q1 2026 worldwide revenues to be in the range of $1.01 billion to $1.03 billion, up 3%-5% year-over-year [57] - For fiscal 2026, the company anticipates worldwide revenue growth of 3%-4% year-over-year [59] Other Important Information - The company repurchased approximately 0.7 million shares of common stock at an average price of $142.87 during Q4 [53] - Cash and cash equivalents as of December 31, 2025, were $1.0949 billion, up $90.3 million sequentially [52] Q&A Session Summary Question: Can you parse apart the improved volume performance? - Management noted stability in markets and effective execution, particularly with DSOs driving growth [71] Question: What are the assumptions for 2026 guidance regarding end markets? - Management expects markets to behave consistently with recent trends and emphasizes active conversion strategies [82] Question: Can you discuss the growth of DSOs and their adoption curve? - Management indicated that DSOs are expanding and that there are good growth parameters in this business [86] Question: What is driving the improvement in the adult business? - Factors include DSO growth, financial credit support, and effective patient conversion strategies [91] Question: How do you view the ASPs for 2026? - Management expects ASPs to be down 1%-2% year-over-year due to country and product mix [101]

Summary of Straumann Group Capital Markets Day 2025 Company Overview - **Company**: Straumann Group - **Event**: Capital Markets Day 2025 - **Date**: November 25, 2025 Key Industry Insights - **Industry**: Dental implants and orthodontics - **Market Trends**: - Shift from globalization to a fragmented market due to local manufacturing policies and tariffs [23][24] - Increased competition from Southeast Asia and China in dental technologies [26][27] - Digitalization and AI are transforming dental practices, enhancing efficiency and profitability [28][60] - Consolidation in dental service organizations (DSOs) is reshaping the market, representing about 30% of total dentistry [29] Financial Performance - **Revenue Growth**: Achieved a 16.2% CAGR from 2021 to 2024 in net revenue, translating to a 9% CAGR in Swiss francs [14] - **EBIT Growth**: 18.5% CAGR from 591 million to 983 million Swiss francs [14] - **Market Share**: Increased implant market share from 29% to 35% [18] Strategic Goals (2026-2030) - **Growth Ambition**: Targeting a double-digit growth CAGR and aiming to transform over 10 million smiles annually by 2030 [11] - **Focus Areas**: - Expanding leadership in implants and orthodontics [43] - Enhancing digital transformation and customer engagement through the Straumann Access platform [49][55] - Strengthening partnerships with DSOs to drive patient flow and treatment adoption [29] Digital Transformation - **Investment in Technology**: Over 50,000 intraoral scanners deployed, with a focus on creating a seamless digital workflow for dental practices [19][50] - **Cloud-Based Platform**: The Straumann Access platform aims to integrate various dental technologies, improving data exchange and collaboration [47][56] - **AI Integration**: AI is being utilized for data segmentation and treatment planning, enhancing the overall patient experience [60][67] Market Potential - **Addressable Market**: Estimated at $20 billion across all segments, with significant under-penetration in implants and orthodontics [36][34] - **Patient Demand**: Growing awareness and demand for high-quality dental treatments, particularly among aging populations [31][32] Competitive Landscape - **Emerging Competitors**: Notable competition from Chinese companies in implants and clear aligners [26][27] - **Response to Competition**: Emphasizing innovation and digitalization to maintain competitive advantage [44][54] Conclusion - **Future Outlook**: Straumann Group is well-positioned for growth through strategic investments in digital transformation, strong market presence, and a focus on customer needs, aiming for sustained revenue growth and profitability in the coming years [54][42]